Nucleai is a spatial biology company that has developed an AI-powered platform to enhance drug development and improve patient outcomes. Nucleai’s platform leverages unique tissue datasets to produce insights into cancer biology, increasing clinical trial efficacy and improving patient care. Nucleai works with leading pharmaceutical companies,licensing its research platform for internal use, and collaborating in biomarkers discovery projects.

AI/ML

Health Care

Nucleai

Avi Veidman

Aviv Levi

Hagar Sachs

Ken Bloom

Neelima Kumar

Jonathan Daniels

Lotan Chorev

Vikas Ahuja

Oscar Puig

Pinchas Birnbaum

Shiri Amir

Alon Lekhtman

Zehavit Rachmiel Arison

Gon Yishay

Yaniv Roth

Tomer Dicker

Shani Caspi

Shai Bookstein

Roni Yichie

Ron Elran

Noah Dolev

Mor Matalon

Morin Blumberg

Lauren Alaluf

Keren Uritsky Gur

Efrat Dicker Sagy

Romi Sadan

Rakefet Rosenstock

Paz Benchetrit

Yoad Cohen

Shir Rosen Zvi

Omer Asyas

Ofek Arviv

Luba Ilfeld

Liza Potikha

Rivka Becky A.

Matthew Alessandri

Madhav Reddy

Liat Ben-Senior MBA MSc

Guy Kolb

Golan Mizrahi

Ettai Markovits

Eliron Amir

Albert Achtenberg

The Business Development and Strategy Team at Nucleai is responsible for identifying and establishing partnerships with leading pharmaceutical companies, driving commercial strategy and operations, and negotiating business agreements. This team focuses on expanding the company’s market presence, developing strategic initiatives to advance Nucleai's AI-powered platform adoption, and supporting biomarker discovery collaborations to ultimately improve drug development and patient outcomes.

Business Development and Strategy Team

Medical Data Team

Data Science Team

Directors

Business Development and Strategy Team

About

Team members

Other teams at Nucleai

Medical Data Team

Data Science Team

Directors